Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:47:48.303Z.
Calculation as of: 2026-10-06T18:47:48.303Z.
Quote observation: 2026-10-06T18:45:08.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b7a441c3924ef4fb7fd11ee72b177fff17d7fc4b92d4d2803dc604c6185f7283
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Relay Therapeutics, Inc.
Market Cap
$4.03B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.03B
Free Cash Flow Yield
N/A
TTM Avg
6.32%
3Y Avg
4.83%
5Y Avg
4.83%
Market Cap
$3.96B
Free Cash Flow Yield
3.86%
TTM Avg
2.45%
3Y Avg
3.11%
5Y Avg
3.04%
Market Cap
$3.85B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.30B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.39B
Free Cash Flow Yield
N/A
TTM Avg
5.69%
3Y Avg
5.69%
5Y Avg
5.69%
Market Cap
$4.43B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.44B
Free Cash Flow Yield
N/A
TTM Avg
4.72%
3Y Avg
3.77%
5Y Avg
4.33%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | $4.03B | N/A | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.03B | N/A | 6.32% | 4.83% | 4.83% |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 3.86% | 2.45% | 3.11% | 3.04% |
| LivaNova PLC (LIVN)vs › | $4.13B | 3.60% | 4.63% | 3.69% | 2.93% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.85B | N/A | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.30B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | N/A | 5.69% | 5.69% | 5.69% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | N/A | 4.72% | 3.77% | 4.33% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | 1.09% | 0.68% | 0.59% | 0.59% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
